Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 3;14(2):11.
doi: 10.1167/tvst.14.2.11.

Deep Learning Approaches to Predict Geographic Atrophy Progression Using Three-Dimensional OCT Imaging

Affiliations

Deep Learning Approaches to Predict Geographic Atrophy Progression Using Three-Dimensional OCT Imaging

Kenta Yoshida et al. Transl Vis Sci Technol. .

Abstract

Purpose: To evaluate the performance of various approaches of processing three-dimensional (3D) optical coherence tomography (OCT) images for deep learning models in predicting area and future growth rate of geographic atrophy (GA) lesions caused by age-related macular degeneration (AMD).

Methods: The study used OCT volumes of GA patients/eyes from the lampalizumab clinical trials (NCT02247479, NCT02247531, NCT02479386); 1219 and 442 study eyes for model development and holdout performance evaluation, respectively. Four approaches were evaluated: (1) en-face intensity maps; (2) SLIVER-net; (3) a 3D convolutional neural network (CNN); and (4) en-face layer thickness and between-layer intensity maps from a segmentation model. The processed OCT images and maps served as input for CNN models to predict baseline GA lesion area size and annualized growth rate.

Results: For the holdout dataset, the Pearson correlation coefficient squared (r2) in the GA growth rate prediction was comparable for all the evaluated approaches (0.33∼0.35). In baseline lesion size prediction, prediction performance was comparable (0.9∼0.91) except for the SLIVER-net (0.83). Prediction performance with only the thickness map of the ellipsoid zone (EZ) or retinal pigment epithelium (RPE) layer individually was inferior to using both. Addition of other layer thickness or intensity maps did not improve the prediction performance.

Conclusions: All explored approaches had comparable performance, which might have reached a plateau to predict GA growth rate. EZ and RPE layers appear to contain the majority of information related to the prediction.

Translational relevance: Our study provides important insights on the utility of 3D OCT images for GA disease progression predictions.

PubMed Disclaimer

Conflict of interest statement

Disclosure: K. Yoshida, Genentech/Roche (E, I); N. Anegondi, Genentech/Roche (E, I), “Multimodal prediction of geographic atrophy growth rate” (P), “Multimodal geographic atrophy lesion segmentation” (P); A. Pely, Genentech/Roche (C); M. Zhang, Genentech/Roche (E, I); F. Debraine, Genentech/Roche (E); K. Ramesh, Genentech/Roche (E); V. Steffen, Genentech/Roche (E, I); S.S. Gao, Genentech/Roche (E, I), “Multimodal prediction of geographic atrophy growth rate” (P); C. Cukras, Genentech/Roche (E, I); C. Rabe, Genentech/Roche (E, I); D. Ferrara, Genentech/Roche (E, I); R.F. Spaide, Roche (C), Regeneron (C), Heidelberg (C), Topcon (C), Bayer (C), Topcon Medical Systems (R); S.R. Sadda, Allergan/AbbVie (C), Apelis (C), Alnylam (C), Amgen (C), Iveric Bio (C), Roche/Genentech (C), Novartis (C), Nanoscope (C), CharacterBio (C), Neurotech (C), NotalVision (C), Eyepoint (C), OcularTx (C), Alkeus (C), 4DMT (C), Oxurion (C), Optos (C), Heidelberg Engineering (C, R, F), iCare (C, F), Novartis (R), Optos (R, F), Carl Zeiss Meditec (R, F), Nidek (R, F), Regeneron (S), RegenxBio (S), Topcon (F); F.G. Holz, Genentech Inc. (F), Bayer (F), Heidelberg Engineering (F, C, R), Zeiss (F, C, R), Optos (F), Apellis (F, C, R), IvericBio/Astellas (F), Novartis (F, C, R), Pixium Vision (F), Bayer (C), Genentech Inc. (C), IvericBio/Astellas (C), Pixium Vision (C), Oxurion (C), Jansen (C); Q. Yang, Genentech/Roche (E, I), “Multimodal prediction of geographic atrophy growth rate” (P)

Figures

Figure 1.
Figure 1.
Overview of the preprocessing steps of OCT images and CNN model architectures for the four approaches evaluated in the study.
Figure 2.
Figure 2.
Prediction performance of the four approaches on (a) the development dataset (cross-validation) and (b) holdout dataset. Cross-validation performance is given as the mean ± SD (black circles and error bars), as well as individual cross-validation fold performance (colored circles), for the square of Pearson correlation coefficient (r2). Holdout performance is given as r2 (± 95% CI, black circles and error bars). Thickness maps for the segmentation outputs were derived as distance between iEZ-iRPE (EZ) and iRPE-oRPE (RPE), where “i” refers to the inner side of and “o” refers to the outer side of the corresponding layers.
Figure 3.
Figure 3.
Prediction performance with various combinations of OCT segmentation layer maps. The table on the left indicates which enface feature maps were included as input to 2D CNN. Cross-validation performance is given as the mean ± SD (black circles and error bars), as well as individual cross-validation fold performance (colored circles), for the square of Pearson correlation coefficient (r2). Thickness and intensity maps of the segmentation outputs were derived as distance or mean intensity between layers, where “i” refers to the inner side of and “o” refers to the outer side of the corresponding layers.

References

    1. Holz FG, Strauss EC, Schmitz-Valckenberg S, van Campagne ML. Geographic atrophy clinical features and potential therapeutic approaches. Ophthalmology. 2014; 121: 1079–1091. - PubMed
    1. Schmidt-Erfurth U, Klimscha S, Waldstein SM, Bogunović H. A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration. Eye. 2017; 31: 26–44. - PMC - PubMed
    1. Chen L, Messinger JD, Sloan KR, et al. .. Nonexudative macular neovascularization supporting outer retina in age-related macular degeneration a clinicopathologic correlation. Ophthalmology. 2020; 127: 931–947. - PubMed
    1. Daich Varela M, Sen S, De Guimaraes TA, et al. .. Artificial intelligence in retinal disease: clinical application, challenges, and future directions. Graefes Arch Clin Exp Ophthalmol. 2023; 261: 3283–3297. - PMC - PubMed
    1. Pfau M, Künzel SH, Pfau K, Schmitz‐Valckenberg S, Fleckenstein M, Holz FG. Multimodal imaging and deep learning in geographic atrophy secondary to age-related macular degeneration. Acta Ophthalmol. 2023; 101: 881–890. - PMC - PubMed